1 / 40

Thyroid Orbitopathy & Glaucoma

Thyroid Orbitopathy & Glaucoma. 高雄醫學大學 眼科 張丞賢. Graves orbitopathy Thyroid associated ophthalmopathy Thyroid eye disease. Shared autoantigen? *EO Muscles 64Kd protein *Adipocyte TSH receptor glycosaminoglycan. Thyroid Orbitopathy. TO Thyroid Orbit

Download Presentation

Thyroid Orbitopathy & Glaucoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Thyroid Orbitopathy& Glaucoma 高雄醫學大學 眼科 張丞賢

  2. Graves orbitopathy Thyroid associated ophthalmopathy Thyroid eye disease Shared autoantigen? *EO Muscles 64Kd protein *Adipocyte TSH receptor glycosaminoglycan Thyroid Orbitopathy TO Thyroid Orbit Autoimmune inflammation

  3. No sign Only sign: lid retraction, lid lag, staring Soft tissue sign: chemosis, congested conj. Proptosis Extraocular myopathy Corneal epithelial defects (Corneal Ulcer) Sight (Optic neuropathy) American Thyroid Association 1977 IOP? Glaucoma? Thyroid Orbitopathy (TO)

  4. Questions • Do TO patients tend to have glaucoma? or ocular hypertension only. • TO-associated ocular hypertension, how does it happen? What is the mechanism? • TO-associated ocular hypertension, do we have to treat? How should we treat?

  5. Question one • Do TO patients tend to have glaucoma? Or ocular hypertension only.

  6. Do TO patients tend to have ocular hypertension or glaucoma? • The prevalence of ocular hypertension and glaucoma in TO patients • TO patients vs. Normal • Ocular HT (22-30 mmHg) :24% (124/500) vs. 5% ??? • Glaucoma (Disc & VF)/Ocular HT:2% vs. 2.7%(IOP 21-25 mmHg), 12% (IOP 26-30 mmHg) 43 months follow • Cockerham, Kennerdell et al, Ophthalmology 1997

  7. Is the above finding consistent? • Prevalence of ocular H/T and glaucoma in a Dutch TO study • Ocular H/T: 4.8% (23/482) • Glaucoma (POAG): 0.8% (4/482) vs 1.1% Dutch general population Kalmann & Mourits BJO 1998 Why???? American vs. European

  8. Measurement of IOP • Applanation • Slight upgaze • IOP increased with upgaze • Compression of episcleral vein by enlarged inferior rectus muscles

  9. IOP change on different vertical gaze Reader A. Ophthalmology 1982

  10. TO: Augmented Δ IOP in upgaze • Normal: 0.6 ± 0.2 mmHg • Graves’ patients without exophthalmos: 4.8 ± 0.4 mmHg • Graves’ patients with exophthalmos: 9.2 ± 1 mmHg • 81 patients Gamblin et al. NEJM 1983

  11. Δ IOP increased with exophthalmos

  12. Time and Increased IOP (ΔIOP)Gamblin GT et al, N Eng J Med 1983)

  13. Augmented Increase of IOP on UpgazeSpierer A, Eisenstein Z. Ophthalmolgy 1991

  14. Augmented Increase of IOP on UpgazeSpierer A, Eisenstein Z. Ophthalmolgy 1991

  15. Other evidence- Increased IOP at upgaze • Adhesive myopathy • Blow-out orbital fracture with inferior rectus muscle incarceration • Orbital myositis Zappia et al. AJO 1971

  16. Back to the Question of Different Prevalence of Ocular Hypertension in TO • American vs. European Studies • Ethnic? • Black, Hispanic and Indian (First Nations) in American Study?

  17. Different subgroups of TO patients and IOPCockerham KP et al, Ophthalmology 1997

  18. Caucasian vs. Oriental • Japanese study • 13% (14/104): (7 POAG + 7 NTG) / TO Ohtsuka & Nakamura Am J Ophthalmol 2000 • Question? • NTG or compressive optic neuropathy • Difference of VF/optic disc change?

  19. V.F. of compressive optic neuropathy • The most common defects found with compression of the optic nerve anterior to the chiasma include enlarged blind spot, relative central scotoma, and constriction. • Nearly all typesof visual field abnormalities have been reported with compression of the optic nerve.

  20. Vancouver (UBC TO data) • Ocular Hypertension Prevalence = 4/85 = 4.7%

  21. Vancouver (UBC TO data) • Increase of IOP at upgaze > 7mmHg = 7/81 = 8.6%

  22. TO-associated ocular hypertension, how does it happen? What is the mechanism? • Angle closure? • Trabecular meshwork, resistance? • Ciliary body, overproduction of aqueous? • Orbit, congested? Hypothesis?

  23. Hypothesis of ocular H/T in TO • Enlarged extraocular muscles • Accumulation of glycosaminoglycan in orbit  Increased orbital pressure  Increased orbital venous pressure (OVP)  Increased episcleral vein pressure (EVP) • Increased IOP OVP æ EVP æ IOP

  24. OVP æ EVP æ IOP • OVP: orbital venous pressure • EVP: episcleral vein pressure • MAP: mean arteral pressure Reitsamerand & Kiel 2002 IVOS

  25. The initial steps of the hypothesis • Enlarged extra-ocular muscles • Accumulation of glycosaminoglycan in orbit ??  Increased orbital pressure  VOP  EVP  IOP Orbital decompression

  26. Intraorbital Pressure(Retrobulbar Pressure, RBP) • Normal “steady state” RBP 3-4.5 mmHg Otto JA et al, BJO1996

  27. To-associated Ocular HypertensionDo we have to treat? How should we treat? • What is the indication to treat? • IOP? • Will treat patients with IOP between 22 and 26 mmHg? Or between 26 and 30? • Other parameters • Optic disc • Visual field

  28. Risk of subsequent glaucomatous visual field lossSommer AJO 1989

  29. Risk factors for developing Glaucoma in TO, Ocular hypertension • Degree of Propotosis • Degree of Myopathy • Exposure to corticosteroid • Prior anti-glaucoma therapy • Family history of glaucoma • Duration of active orbitopathy Cockerham et al, Ophthalmology 1997

  30. To-associated Ocular HypertensionDo we have to treat? How should we treat? • Reduce the aqueous production – • b blocker, CAI, a2 agonist • Facilitate aqueous outflow – • Miotics, a agonist • Prostaglandin • Hyperosmotic agent • Sugar-based medication, Manitol • Others? • Surgery, TRBC

  31. Orbital DecompressionKalmann and Mourits BJO 1998, Dev et al. 1998 CJO 23  18 mmHg

  32. IOP decreased after Tx in TO • Inferior rectus muscle recession Kalmann and Mouritiz BJO1998 • Botulinum toxin injection for myopathic strabismus Kikkawa et al. AJO 2003

  33. How about Hypothyroidism? • TO mostly hyperthyroidism • Hypothyroidism • No proptosis • No enlargement of EOM • No restrictive myopathy

  34. Hypothyroidism association with POAG or NTG • Controversial • Autoimmune • Deposition of mucopolysacharide in trabecualr meshwork

  35. Conclusion • Ocular Hypertension in TO • Subgroup of enlarged / restrictive EOM • D.D. compressive optic neuropathy • Treatment • Medical : inhibition of aqueous production, b-blocker, CAI • Orbital decompression, muscle recession, botulinum injection

  36. Appreciation • 吳國揚 會長 • 蔡榮坤 主任 • 高醫眼科 所有住院醫師 • 林玫琪 小姐 (MSD) • 林斐嬋 小姐 (南區眼科醫師會秘書) • 南區眼科醫師

More Related